Sastasundar Ventures Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
Sastasundar Ventures Ltd · Outcome · 14 Nov 2026, 8:45 pm
Sastasundar Ventures Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 48,409 (+60.7% YoY | +8.3% QoQ) ■ EBITDA: -2,224 (+1.7% YoY | -165.7% QoQ) ■ EBITDA Margin (%): -4.6 (+291 bps YoY | -272 bps QoQ) ■ PAT: -1,104 (+13.0% YoY | Profit to Loss QoQ) ■ EPS (INR): -3.47 (+13.0% YoY | Profit to Loss QoQ) Sastasundar Ventures Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) Segmental Performance Financial Services ■ Revenue: -501 (+24.3% YoY | Positive to Negative QoQ) ■ EBIT: -574 (+22.0% YoY | Profit to Loss QoQ) ■ EBIT Margin (%): 114 (+340 bps YoY | +2943 bps QoQ) Healthcare Network ■ Revenue: 48,622 (+57.9% YoY | +18.1% QoQ) ■ EBIT: -1,387 (+10.2% YoY | +6.7% QoQ) ■ EBIT Margin (%): -2.9 (+217 bps YoY | +76 bps QoQ) Others ■ Revenue: 288 (-89.9% QoQ) ■ EBIT: 17.7 (-67.7% QoQ) ■ EBIT Margin (%): 6.1 (+421 bps QoQ)
Original exchange filing (PDF)
More announcements from Sastasundar Ventures Ltd
- Disclosure under Listing Regulations - Submission of Audio recording of the Earnings Conference call for Q2 FY27 · 17 Nov 2026
- Please find attached the Investor Presentation. · 14 Nov 2026
- Please find attached the unaudited financial results for the quarter and half year ended 30th September, 2026 · 14 Nov 2026
- Intimation of Schedule of the Earnings Conference Call for Q2 of FY2026-27 and registration Link thereof · 16 Nov 2026
- To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on 30th September, 2026 · 14 Nov 2026
- HEALTH X PLATFORM LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . · 14 Nov 2026
- Health X Platform Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve the Unaudited Standalone .... · 14 Nov 2026
- Disclosure of Voting Results of the 37th AGM of the Company held on Monday, 28th September, 2026 · 29 Sept 2026
